カテゴリ： 世界, 医療/バイオ, QYResearch

変形性関節症幹細胞治療の世界市場2023年：同種、自家

■ 英語タイトル：Global Stem Cell Therapy for Osteoarthritis Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8898）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8898
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：65
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[変形性関節症幹細胞治療の世界市場2023年：同種、自家]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は変形性関節症幹細胞治療のグローバル市場について調査・分析し、世界の変形性関節症幹細胞治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（同種、自家）、用途別セグメント分析（原発性変形性関節症、二次性変形性関節症）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medipost、Nature Cell、Theracell Advanced Biotechnology、Takeda (TiGenix)などが含まれています。変形性関節症幹細胞治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、変形性関節症幹細胞治療市場規模を算出する際に考慮しました。

・変形性関節症幹細胞治療市場の概要
- 変形性関節症幹細胞治療の種類別セグメント
- 世界の変形性関節症幹細胞治療市場規模：タイプ別分析（同種、自家）
- 変形性関節症幹細胞治療の用途別セグメント
- 世界の変形性関節症幹細胞治療市場規模：用途別分析（原発性変形性関節症、二次性変形性関節症）
- 世界の変形性関節症幹細胞治療市場規模予測（2018年-2029年）

・変形性関節症幹細胞治療市場の成長トレンド
- 変形性関節症幹細胞治療の地域別市場規模（2018年-2029年）
- 変形性関節症幹細胞治療市場ダイナミクス
- 変形性関節症幹細胞治療の業界動向
- 変形性関節症幹細胞治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：同種、自家
- 世界の変形性関節症幹細胞治療のタイプ別市場規模（2018年-2023年）
- 世界の変形性関節症幹細胞治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：原発性変形性関節症、二次性変形性関節症
- 世界の変形性関節症幹細胞治療の用途別市場規模（2018年-2023年）
- 世界の変形性関節症幹細胞治療の用途別市場規模（2024年-2029年）

・変形性関節症幹細胞治療の地域別市場規模
- 北米の変形性関節症幹細胞治療市場規模（2018年-2029年）
- 米国の変形性関節症幹細胞治療市場規模（2018年-2029年）
- ヨーロッパの変形性関節症幹細胞治療市場規模（2018年-2029年）
- アジア太平洋の変形性関節症幹細胞治療市場規模（2018年-2029年）
- 中国の変形性関節症幹細胞治療市場規模（2018年-2029年）
- 日本の変形性関節症幹細胞治療市場規模（2018年-2029年）
- 韓国の変形性関節症幹細胞治療市場規模（2018年-2029年）
- インドの変形性関節症幹細胞治療市場規模（2018年-2029年）
- オーストラリアの変形性関節症幹細胞治療市場規模（2018年-2029年）
- 中南米の変形性関節症幹細胞治療市場規模（2018年-2029年）
- 中東・アフリカの変形性関節症幹細胞治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Medipost、Nature Cell、Theracell Advanced Biotechnology、Takeda (TiGenix)

・アナリストの観点/結論

・調査手法と情報源

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.
Stem cells are the body’s raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
Highlights
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ 28 million in 2022 and is anticipated to reach US$ 107.3 million by 2029, witnessing a CAGR of 25.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis.
The Stem Cell Therapy for Osteoarthritis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stem Cell Therapy for Osteoarthritis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy for Osteoarthritis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Segment by Type
Allogeneic
Autologous
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2018-2029)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2018-2023)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2024-2029)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2018-2023)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2018-2023)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2022
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2018-2023)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2024-2029)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2018-2023)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2018-2023)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Detail
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.1.5 Medipost Recent Development
11.2 Nature Cell
11.2.1 Nature Cell Company Detail
11.2.2 Nature Cell Business Overview
11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.2.5 Nature Cell Recent Development
11.3 Theracell Advanced Biotechnology
11.3.1 Theracell Advanced Biotechnology Company Detail
11.3.2 Theracell Advanced Biotechnology Business Overview
11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.3.5 Theracell Advanced Biotechnology Recent Development
11.4 Takeda (TiGenix)
11.4.1 Takeda (TiGenix) Company Detail
11.4.2 Takeda (TiGenix) Business Overview
11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.4.5 Takeda (TiGenix) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2018-2023)
Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2024-2029)
Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2018-2023)
Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2022)
Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2018-2023)
Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2024-2029)
Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2018-2023)
Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2024-2029)
Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029) & (US$ Million)
Table 46. Medipost Company Detail
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy for Osteoarthritis Product
Table 49. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023) & (US$ Million)
Table 50. Medipost Recent Development
Table 51. Nature Cell Company Detail
Table 52. Nature Cell Business Overview
Table 53. Nature Cell Stem Cell Therapy for Osteoarthritis Product
Table 54. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023) & (US$ Million)
Table 55. Nature Cell Recent Development
Table 56. Theracell Advanced Biotechnology Company Detail
Table 57. Theracell Advanced Biotechnology Business Overview
Table 58. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
Table 59. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023) & (US$ Million)
Table 60. Theracell Advanced Biotechnology Recent Development
Table 61. Takeda (TiGenix) Company Detail
Table 62. Takeda (TiGenix) Business Overview
Table 63. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product
Table 64. Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023) & (US$ Million)
Table 65. Takeda (TiGenix) Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2022 VS 2029
Figure 3. Allogeneic Features
Figure 4. Autologous Features
Figure 5. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2022 VS 2029
Figure 7. Primary Osteoarthritis Case Studies
Figure 8. Secondary Osteoarthritis Case Studies
Figure 9. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Region: 2022 VS 2029
Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2022
Figure 14. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2022
Figure 16. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2018-2029)
Figure 18. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2018-2029)
Figure 22. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2018-2029)
Figure 30. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2018-2029)
Figure 38. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2018-2029)
Figure 42. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
Figure 45. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
Figure 46. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
Figure 47. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 間葉系幹細胞（MSC）療法のグローバル市場展望 2023年-2029年：静脈内（IV）、経鼻（IN）、関節内（IA）、その他
  • 創傷治癒用幹細胞治療のグローバル市場展望 2023年-2029年：間葉系幹細胞、脂肪由来幹細胞、骨髄由来幹細胞、胚性幹細胞、その他
  • 細胞療法モニタリングキットの世界市場2023年：細胞活性化キット、免疫細胞分化＆増殖キット、幹細胞キット、その他
  • CAR-T細胞治療薬のグローバル市場展望 2023年-2029年：CD19標的、BCMA標的
  • 万能細胞治療薬のグローバル市場展望 2023年-2029年：細胞治療、遺伝子治療、幹細胞治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8898 )"変形性関節症幹細胞治療の世界市場2023年：同種、自家" (英文：Global Stem Cell Therapy for Osteoarthritis Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。